Filing

Oric Pharmaceuticals, Inc. Filed 2022-03-21 Acc 0001193125-22-080510

Documents 1

2022-03-25 4 President and CEO bought 350,000 shares at an average $4.92 ($1,723,708)
2022-03-22 S-8 Securities Offered to Employees in Benefit Plans
2022-03-22 POS AM Post-effective Amendment for Registration Statement
2022-03-21 8-K Regulation FD disclosure
2022-03-21 8-K Results of operations
2022-03-21 POSASR POSASR
2022-03-21 10-K Annual Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading d335806dposasr.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…